Skip to content
10-K

Annual Report

INTERNATIONAL STEM CELL CORPORATION ISCO

0000950170-23-010977

← back to feed
Filed
Mar 30, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 27, 2023 8M sh
Shares Diluted FY 2022 · Dec 31, 2021 7.83M sh
Capex FY 2022 · Dec 31, 2021 $23K
Operating Cash Flow FY 2022 · Dec 31, 2021 −$1.3M
Current Liabilities FY 2022 · Dec 31, 2021 $4.28M
Total Liabilities FY 2022 · Dec 31, 2021 $5.23M
Current Assets FY 2022 · Dec 31, 2021 $2.33M
Total Assets FY 2022 · Dec 31, 2021 $4.95M
Eps Diluted FY 2022 · Dec 31, 2021 −$0.11
Eps Basic FY 2022 · Dec 31, 2021 −$0.11
Sga Expense FY 2022 · Dec 31, 2021 $4.08M
Rd Expense FY 2022 · Dec 31, 2021 $695K
Net Income FY 2022 · Dec 31, 2021 −$899K
Operating Income FY 2022 · Dec 31, 2021 −$1.92M
Cost Of Revenue FY 2022 · Dec 31, 2021 $2.94M
Revenue FY 2022 · Dec 31, 2021 $7.18M
Stockholders Equity FY 2022 · Dec 31, 2020 −$4.33M